447
Views
9
CrossRef citations to date
0
Altmetric
Review

Toward a personalized therapy for panic disorder: preliminary considerations from a work in progress

&
Pages 1957-1970 | Published online: 11 Jul 2019

References

  • American Psychiatric Association. Practice guideline for the treatment of patients with panic disorder. 2009 Available from: https://psychiatryonline.org/pb/assets/raw/sitewide/practice_guidelines/guidelines/panicdisorder.pdf. Accessed 69, 2018.
  • National Institute for Health and Clinical Excellence. Generalised anxiety disorder and panic disorder (with or without agoraphobia) in adults, management. 2011 Available from: https://www.nice.org.uk/guidance/cg113. Accessed 69, 2018.
  • Bandelow B, Michaelis S, Wedekind D. Treatment of anxiety disorders. Dialogues Clin Neurosci. 2017;19(2):93–107.28867934
  • Caldirola D, Alciati A, Riva A, Perna G. Are there advances in pharmacotherapy for panic disorder? A systematic review of the past five years. Expert Opin Pharmacother. 2018;19(12):1357–1368. doi:10.1080/14656566.2018.150492130063164
  • Perna G, Caldirola D. Management of treatment-resistant panic disorder. Curr Treat Options Psychiatry. 2017;4(4):371–386. doi:10.1007/s40501-017-0128-729238651
  • Perna G, Grassi M, Caldirola D, Nemeroff CB. The revolution of personalized psychiatry: will technology make it happen sooner? Psychol Med. 2018;48(5):705–713. doi:10.1017/S003329171700285928967349
  • Perna G, Caldirola D. Is panic disorder a disorder of physical fitness? A heuristic proposal. F1000Res. 2018;7:294. doi:10.12688/f1000research29623195
  • Bouton ME, Mineka S, Barlow DH. A modern learning theory perspective on the etiology of panic disorder. Psychol Rev. 2001;108(1):4–32.11212632
  • De Cort K, Griez E, Buchler M, Schruers K. The role of “interoceptive” fear conditioning in the development of panic disorder. Behav Ther. 2012;43(1):203–215. doi:10.1016/j.beth.2011.06.00522304891
  • Briggs AC, Stretch DD, Brandon S. Subtyping of panic disorder by symptom profile. Br J Psychiatry. 1993;163:201–209.8075912
  • Meuret AE, White KS, Ritz T, Roth WT, Hofmann SG, Brown TA. Panic attack symptom dimensions and their relationship to illness characteristics in panic disorder. J Psychiatr Res. 2006;40(6):520–527. doi:10.1016/j.jpsychires.2005.09.00616293263
  • Kircanski K, Craske MG, Epstein AM, Wittchen HU. Subtypes of panic attacks: a critical review of the empirical literature. Depress Anxiety. 2009;26(10):878–887. doi:10.1002/da.2060319750553
  • Roberson-Nay R, Kendler KS. Panic disorder and its subtypes: a comprehensive analysis of panic symptom heterogeneity using epidemiological and treatment seeking samples. Psychol Med. 2011;41(11):2411–2421. doi:10.1017/S003329171100054721557895
  • Roberson-Nay R, Latendresse SJ, Kendler KS. A latent class approach to the external validation of respiratory and non-respiratory panic subtypes. Psychol Med. 2012;42(3):461–474. doi:10.1017/S003329171100142521846423
  • Freire RC, Perna G, Nardi AE. Panic disorder respiratory subtype: psychopathology, laboratory challenge tests, and response to treatment. Harv Rev Psychiatry. 2010;18(4):220–229. doi:10.3109/10673229.2010.49374420597592
  • Wilhelm FH, Trabert W, Roth WT. Physiologic instability in panic disorder and generalized anxiety disorder. Biol Psychiatry. 2001;49(7):596–605.11297717
  • Biber B, Alkin T. Panic disorder subtypes: differential responses to CO2 challenge. Am J Psychiatry. 1999;156(5):739–744. doi:10.1176/ajp.156.5.73910327907
  • Valenca AM, Nardi AE, Nascimento I, Zin WA, Versiani M. Respiratory panic disorder subtype and sensitivity to the carbon dioxide challenge test. Braz J Med Biol Res. 2002;35(7):783–788. doi:10.1590/s0100-879x200200070000412131917
  • Zugliani MM, Freire RC, Perna G, Crippa JA, Nardi AE. Laboratory, clinical and therapeutic features of respiratory panic disorder subtype. CNS Neurol Disord Drug Targets. 2015;14(5):627–635.25924997
  • Niccolai V, van Duinen MA, Griez EJ. Respiratory patterns in panic disorder reviewed: a focus on biological challenge tests. Acta Psychiatr Scand. 2009;120(3):167–177. doi:10.1111/j.1600-0447.2009.01408.x19548964
  • Grassi M, Caldirola D, Di Chiaro NV, et al. Are respiratory abnormalities specific for panic disorder? A meta-analysis. Neuropsychobiology. 2014;70(1):52–60. doi:10.1159/00036483025247676
  • Grassi M, Caldirola D, Vanni G, et al. Baseline respiratory parameters in panic disorder: a meta-analysis. J Affect Disord. 2013;146(2):158–173. doi:10.1016/j.jad.2012.08.03423107756
  • Yamada T, Inoue A, Mafune K, Hiro H, Nagata S. Recovery of percent vital capacity by breathing training in patients with panic disorder and impaired diaphragmatic breathing. Behav Modif. 2017;41(5):665–682. doi:10.1177/014544551771143628670907
  • Meuret AE, Rosenfield D, Wilhelm FH, et al. Do unexpected panic attacks occur spontaneously? Biol Psychiatry. 2011;70(10):985–991. doi:10.1016/j.biopsych.2011.05.02721783179
  • Beria P, Viana ACW, Behenck A, et al. Respiratory subtype of panic disorder: can serum phosphate levels be a possible outcome to group cognitive-behavior therapy? J Affect Disord. 2018;235:474–479. doi:10.1016/j.jad.2018.04.00229680728
  • Burkhardt SC, Wilhelm FH, Meuret AE, Blechert J, Roth WT. Temporal stability and coherence of anxiety, dyspnea, and physiological variables in panic disorder. Biol Psychol. 2010;85(2):226–232. doi:10.1016/j.biopsycho.2010.07.00520637257
  • Bakhshaie J, Zvolensky MJ, Goodwin RD. Cigarette smoking and the onset and persistence of panic attacks during mid-adulthood in the United States: 1994–2005. J Clin Psychiatry. 2016;77(1):e21–e24. doi:10.4088/JCP.14m0929026845274
  • Cosci F, Knuts IJ, Abrams K, Griez EJ, Schruers KR. Cigarette smoking and panic: a critical review of the literature. J Clin Psychiatry. 2010;71(5):606–615. doi:10.4088/JCP.08r04523blu19961810
  • Liu Y, Sareen J, Bolton J, Wang J. Development and validation of a risk-prediction algorithm for the recurrence of panic disorder. Depress Anxiety. 2015;32(5):341–348. doi:10.1002/da.2235925774487
  • Knuts IJ, Cosci F, Esquivel G, et al. Cigarette smoking and 35% CO(2) induced panic in panic disorder patients. J Affect Disord. 2010;124(1–2):215–218. doi:10.1016/j.jad.2009.10.01219896718
  • Caldirola D, Bellodi L, Cammino S, Perna G. Smoking and respiratory irregularity in panic disorder. Biol Psychiatry. 2004;56(6):393–398. doi:10.1016/j.biopsych.2004.06.01315364036
  • Goodwin RD, Eaton WW. Asthma and the risk of panic attacks among adults in the community. Psychol Med. 2003;33(5):879–885.12877402
  • Goodwin RD, Pine DS, Hoven CW. Asthma and panic attacks among youth in the community. J Asthma. 2003;40(2):139–145.12765315
  • Perna G, Bertani A, Politi E, Colombo G, Bellodi L. Asthma and panic attacks. Biol Psychiatry. 1997;42(7):625–630. doi:10.1016/S0006-3223(96)00436-29376459
  • Boudreau M, Bacon SL, Paine NJ, et al. Impact of panic attacks on bronchoconstriction and subjective distress in asthma patients with and without panic disorder. Psychosom Med. 2017;79(5):576–584. doi:10.1097/PSY.000000000000044328033197
  • Hasler G, Gergen PJ, Kleinbaum DG, et al. Asthma and panic in young adults: a 20-year prospective community study. Am J Respir Crit Care Med. 2005;171(11):1224–1230. doi:10.1164/rccm.200412-1669OC15764721
  • Johnson AL, McLeish AC. Differences in panic psychopathology between smokers with and without asthma. Psychol Health Med. 2017;22(1):110–120. doi:10.1080/13548506.2016.115367626911387
  • Perna G, Bertani A, Caldirola D, Gabriele A, Cocchi S, Bellodi L. Antipanic drug modulation of 35% CO2 hyperreactivity and short-term treatment outcome. J Clin Psychopharmacol. 2002;22(3):300–308.12006901
  • Sardinha A, Freire RC, Zin WA, Nardi AE. Respiratory manifestations of panic disorder: causes, consequences and therapeutic implications. J Bras Pneumol. 2009;35(7):698–708. doi:10.1590/s1806-3713200900070001219669009
  • Pols H, Verburg K, Hauzer R, Meijer J, Griez E. Alprazolam premedication and 35% carbon dioxide vulnerability in panic patients. Biol Psychiatry. 1996;40(9):913–917. doi:10.1016/0006-3223(95)00494-78896779
  • Valenca AM, Nardi AE, Nascimento I, et al. Early carbon dioxide challenge test may predict clinical response in panic disorder. Psychiatry Res. 2002;112(3):269–272.12450637
  • Nardi AE, Valenca AM, Nascimento I, et al. A three-year follow-up study of patients with the respiratory subtype of panic disorder after treatment with clonazepam. Psychiatry Res. 2005;137(1–2):61–70. doi:10.1016/j.psychres.2005.05.01116226812
  • Bertani A, Bellodi L, Bussi R, Caldirola D, Cucchi M, Perna G. The effect of one-week treatment with venlafaxine on 35% CO2 hyperreactivity in patients with panic disorder: an open study. J Clin Psychopharmacol. 2003;23(1):106–108.12544387
  • Gorman JM, Browne ST, Papp LA, et al. Effect of antipanic treatment on response to carbon dioxide. Biol Psychiatry. 1997;42(11):982–991.9386849
  • Gorman JM, Fyer AJ, Ross DC, et al. Normalization of venous pH, pCO2, and bicarbonate levels after blockade of panic attacks. Psychiatry Res. 1985;14(1):57–65.3921997
  • Perez-Costillas L, Montes MR, Martinez-Ortega JM, et al. Phosphate levels as a possible state marker in panic disorder: preliminary study of a feasible laboratory measure for routine clinical practice. J Psychiatr Res. 2013;47(10):1357–1362. doi:10.1016/j.jpsychires.2013.05.02223806579
  • Perna G, Bertani A, Caldirola D, et al. Modulation of hyperreactivity to 35% CO2 after one week of treatment with paroxetine and reboxetine: a double-blind, randomized study. J Clin Psychopharmacol. 2004;24(3):277–282.15118481
  • Bertani A, Perna G, Migliarese G, et al. Comparison of the treatment with paroxetine and reboxetine in panic disorder: a randomized, single-blind study. Pharmacopsychiatry. 2004;37(5):206–210. doi:10.1055/s-2004-83259315359375
  • Song HM, Kim JH, Heo JY, Yu BH. Clinical characteristics of the respiratory subtype in panic disorder patients. Psychiatry Investig. 2014;11(4):412–418. doi:10.4306/pi.2014.11.4.412
  • Perna G, Bertani A, Caldirola D, Smeraldi E, Bellodi L. A comparison of citalopram and paroxetine in the treatment of panic disorder: a randomized, single-blind study. Pharmacopsychiatry. 2001;34(3):85–90. doi:10.1055/s-2001-1428311434404
  • Yeragani VK, Rao R, Tancer M, Uhde T. Paroxetine decreases respiratory irregularity of linear and nonlinear measures of respiration in patients with panic disorder. A preliminary report. Neuropsychobiology. 2004;49(2):53–57. doi:10.1159/00007641014981334
  • Meuret AE, Wilhelm FH, Ritz T, Roth WT. Feedback of end-tidal pCO2 as a therapeutic approach for panic disorder. J Psychiatr Res. 2008;42(7):560–568. doi:10.1016/j.jpsychires.2007.06.00517681544
  • Tolin DF, McGrath PB, Hale LR, Weiner DN, Gueorguieva R. A multisite benchmarking trial of capnometry guided respiratory intervention for panic disorder in naturalistic treatment settings. Appl Psychophysiol Biofeedback. 2017;42(1):51–58. doi:10.1007/s10484-017-9354-428194546
  • Meuret AE, Rosenfield D, Seidel A, Bhaskara L, Hofmann SG. Respiratory and cognitive mediators of treatment change in panic disorder: evidence for intervention specificity. J Consult Clin Psychol. 2010;78(5):691–704. doi:10.1037/a001955220873904
  • Meuret AE, Rosenfield D, Hofmann SG, Suvak MK, Roth WT. Changes in respiration mediate changes in fear of bodily sensations in panic disorder. J Psychiatr Res. 2009;43(6):634–641. doi:10.1016/j.jpsychires.2008.08.00318835608
  • Davies CD, Craske MG. Low baseline pCO2 predicts poorer outcome from behavioral treatment: evidence from a mixed anxiety disorders sample. Psychiatry Res. 2014;219(2):311–315. doi:10.1016/j.psychres.2014.06.00324953422
  • Kim S, Wollburg E, Roth WT. Opposing breathing therapies for panic disorder: a randomized controlled trial of lowering vs raising end-tidal P(CO₂). J Clin Psychiatry. 2012;73(7):931–939. doi:10.4088/JCP.11m0706822901344
  • Livermore N, Sharpe L, McKenzie D. Panic attacks and panic disorder in chronic obstructive pulmonary disease: a cognitive behavioral perspective. Respir Med. 2010;104(9):1246–1253. doi:10.1016/j.rmed.2010.04.01120457513
  • Laurino RA, Barnabe V, Saraiva-Romanholo BM, et al. Respiratory rehabilitation: a physiotherapy approach to the control of asthma symptoms and anxiety. Clinics (Sao Paulo). 2012;67(11):1291–1297. doi:10.6061/clinics/2012(11)1223184206
  • Leibold NK, Schruers KR. Assessing panic: bridging the gap between fundamental mechanisms and daily life experience. Front Neurosci. 2018;12:785. doi:10.3389/fnins.2018.0004430459546
  • Caldirola D, Schruers KR, Nardi AE, et al. Is there cardiac risk in panic disorder? An updated systematic review. J Affect Disord. 2016;194:38–49. doi:10.1016/j.jad.2016.01.00326802506
  • Belem Da Silva CT, Schuch F, Costa M, Hirakata V, Manfro GG. Somatic, but not cognitive, symptoms of anxiety predict lower levels of physical activity in panic disorder patients. J Affect Disord. 2014;164:63–68. doi:10.1016/j.jad.2014.04.00724856555
  • Muotri RW, Bernik MA. Panic disorder and exercise avoidance. Rev Bras Psiquiatr. 2014;36(1):68–75. doi:10.1590/1516-4446-2012-101224604463
  • Caldirola D, Namia C, Micieli W, et al. Cardiorespiratory response to physical exercise and psychological variables in panic disorder. Rev Bras Psiquiatr. 2011;33(4):385–389.22189929
  • Muotri RW, Bernik MA, Neto FL. Misinterpretation of the Borg’s Rating of Perceived Exertion Scale by patients with panic disorder during ergospirometry challenge. BMJ Open Sport Exerc Med. 2017;3(1):e000164. doi:10.1136/bmjsem-2017-000232
  • Pfaltz MC, Kolodyazhniy V, Blechert J, et al. Metabolic decoupling in daily life in patients with panic disorder and agoraphobia. J Psychiatr Res. 2015;68:377–383. doi:10.1016/j.jpsychires.2015.04.02726028550
  • Machado S, Sancassiani F, Paes F, et al. Panic disorder and cardiovascular diseases: an overview. Int Rev Psychiatry. 2017;29(5):436–444. doi:10.1080/09540261.2017.135754028893114
  • Meier C, Harbrecht U, Liedtke R, et al. Relative hyperhomocysteinemia in patients with panic disorder: a case-control study. Neuropsychobiology. 2010;62(3):164–170. doi:10.1159/00031857320628267
  • Yapislar H, Aydogan S, Ozum U. Biological understanding of the cardiovascular risk associated with major depression and panic disorder is important. Int J Psychiatry Clin Pract. 2012;16(1):27–32. doi:10.3109/13651501.2011.62012722122655
  • Asoglu M, Aslan M, Imre O, et al. Mean platelet volume and red cell distribution width levels in initial evaluation of panic disorder. Neuropsychiatr Dis Treat. 2016;12:2435–2438. doi:10.2147/NDT.S11110827703361
  • Kokacya MH, Copoglu US, Kivrak Y, et al. Increased mean platelet volume in patients with panic disorder. Neuropsychiatr Dis Treat. 2015;11:2629–2633. doi:10.2147/NDT.S9414726508858
  • Glaus J, von Kanel R, Lasserre AM, et al. The bidirectional relationship between anxiety disorders and circulating levels of inflammatory markers: results from a large longitudinal population-based study. Depress Anxiety. 2018;35(4):360–371. doi:10.1002/da.2271029244900
  • Perna G, Iannone G, Alciati A, Caldirola D. Are anxiety disorders associated with accelerated aging? A focus on neuroprogression. Neural Plast. 2016;2016:8457612. doi:10.1155/2016/526067126881136
  • Quagliato LA, Nardi AE. Cytokine alterations in panic disorder: A systematic review. J Affect Disord. 2018;228:91–96. doi:10.1016/j.jad.2017.11.09429241050
  • Tucker P, Adamson P, Miranda R Jr, et al. Paroxetine increases heart rate variability in panic disorder. J Clin Psychopharmacol. 1997;17(5):370–376.9315988
  • Yeragani VK, Jampala VC, Sobelewski E, Kay J, Igel G. Effects of paroxetine on heart period variability in patients with panic disorder: a study of holter ECG records. Neuropsychobiology. 1999;40(3):124–128. doi:10.1159/00002660810494046
  • Yeragani VK, Rao R. Effect of nortriptyline and paroxetine on measures of chaos of heart rate time series in patients with panic disorder. J Psychosom Res. 2003;55(6):507–513.14642980
  • Yeragani VK, Pohl R, Jampala VC, et al. Effects of nortriptyline and paroxetine on QT variability in patients with panic disorder. Depress Anxiety. 2000;11(3):126–130.10875054
  • Choi KW, Jang EH, Kim AY, et al. Heart rate variability for treatment response between patients with major depressive disorder versus panic disorder: A 12-week follow-up study. J Affect Disord. 2019;246:157–165. doi:10.1016/j.jad.2018.12.04830583140
  • Prasko J, Latalova K, Diveky T, et al. Panic disorder, autonomic nervous system and dissociation - changes during therapy. Neuro Endocrinol Lett. 2011;32(5):641–651.22167145
  • Baker B, Khaykin Y, Devins G, et al. Correlates of therapeutic response in panic disorder presenting with palpitations: heart rate variability, sleep, and placebo effect. Can J Psychiatry. 2003;48(6):381–387. doi:10.1177/07067437030480060412894612
  • Chalmers JA, Quintana DS, Abbott MJ, Kemp AH. Anxiety disorders are associated with reduced heart rate variability: a meta-analysis. Front Psychiatry. 2014;5:80. doi:10.3389/fpsyt.2014.0008025071612
  • Kahn JP, Veras AB, Nardi AE, Curtis AB. Clonazepam treatment of atrial fibrillation in panic anxiety patients: a case series. Psychosomatics. 2018. doi:10.1016/j.psym.2018.12.001
  • Beach SR, Kostis WJ, Celano CM, et al. Meta-analysis of selective serotonin reuptake inhibitor-associated QTc prolongation. J Clin Psychiatry. 2014;75(5):e441–e449. doi:10.4088/JCP.13r0867224922496
  • Celano CM, Daunis DJ, Lokko HN, Campbell KA, Huffman JC. Anxiety disorders and cardiovascular disease. Curr Psychiatry Rep. 2016;18(11):101. doi:10.1007/s11920-016-0739-527671918
  • Herran A, Ramirez ML, Carrera M, et al. Panic disorder, treatment with selective serotonin reuptake inhibitors, and cholesterol levels. J Clin Psychopharmacol. 2006;26(5):538–540. doi:10.1097/01.jcp.0000237941.56107.b716974205
  • Le Melledo JM, Mailo K, Lara N, et al. Paroxetine-induced increase in LDL cholesterol levels. J Psychopharmacol. 2009;23(7):826–830. doi:10.1177/026988110809432019074543
  • Nezafati MH, Eshraghi A, Vojdanparast M, Abtahi S, Nezafati P. Selective serotonin reuptake inhibitors and cardiovascular events: A systematic review. J Res Med Sci. 2016;21:66. doi:10.4103/1735-1995.18964727904611
  • Bartley CA, Hay M, Bloch MH. Meta-analysis: aerobic exercise for the treatment of anxiety disorders. Prog Neuropsychopharmacol Biol Psychiatry. 2013;45:34–39. doi:10.1016/j.pnpbp.2013.04.01623643675
  • Gaudlitz K, Plag J, Dimeo F, Strohle A. Aerobic exercise training facilitates the effectiveness of cognitive behavioral therapy in panic disorder. Depress Anxiety. 2015;32(3):221–228. doi:10.1002/da.2233725515221
  • Lamego MK, Lattari E, Souza de Sá Filho A, et al. Aerobic exercise reduces anxiety symptoms and improves fitness in patients with panic disorder. Med Express (São Paulo, Online). 2016;3(3):M160306.
  • Bischoff S, Wieder G, Einsle F, et al. Running for extinction? Aerobic exercise as an augmentation of exposure therapy in panic disorder with agoraphobia. J Psychiatr Res. 2018;101:34–41. doi:10.1016/j.jpsychires.2018.03.00129539585
  • Plag J, Ergec DL, Fydrich T, Strohle A. High-intensity interval training in panic disorder patients: a pilot study. J Nerv Ment Dis. 2019;207(3):184–187. doi:10.1097/NMD.000000000000094430724830
  • Esquivel G, Diaz-Galvis J, Schruers K, et al. Acute exercise reduces the effects of a 35% CO2 challenge in patients with panic disorder. J Affect Disord. 2008;107(1–3):217–220. doi:10.1016/j.jad.2007.07.02217727960
  • Elstad M, O’Callaghan EL, Smith AJ, Ben-Tal A, Ramchandra R. Cardiorespiratory interactions in humans and animals: rhythms for life. Am J Physiol Heart Circ Physiol. 2018;315(1):H6–H17. doi:10.1152/ajpheart.00701.201729522373
  • Morkl S, Wagner-Skacel J, Lahousen T. et al. The role of nutrition and the gut-brain axis in psychiatry: a review of the literature. Neuropsychobiology. 2018;1–9. doi:10.1159/000492834
  • Perna G, Dario A, Caldirola D, et al. Panic disorder: the role of the balance system. J Psychiatr Res. 2001;35(5):279–286.11591430
  • Caldirola D, Teggi R, Bondi S, et al. Is there a hypersensitive visual alarm system in panic disorder? Psychiatry Res. 2011;187(3):387–391. doi:10.1016/j.psychres.2010.05.01221477868
  • Perna G, Alpini D, Caldirola D, Raponi G, Cesarani A, Bellodi L. Serotonergic modulation of the balance system in panic disorder: an open study. Depress Anxiety. 2003;17(2):101–106. doi:10.1002/da.1009212621600
  • Teggi R, Caldirola D, Bondi S, Perna G, Bellodi L, Bussi M. Vestibular testing in patients with panic disorder and chronic dizziness. Acta Otorhinolaryngol Ital. 2007;27(5):243–247.18198754
  • Teggi R, Caldirola D, Colombo B, et al. Dizziness, migrainous vertigo and psychiatric disorders. J Laryngol Otol. 2010;124(3):285–290. doi:10.1017/S002221510999197619954562
  • Coelho CM, Balaban CD. Visuo-vestibular contributions to anxiety and fear. Neurosci Biobehav Rev. 2015;48:148–159. doi:10.1016/j.neubiorev.2014.10.02325451199
  • Mezzasalma MA, Mathias Kde V, Nascimento I, Valenca AM, Nardi AE. Imipramine for vestibular dysfunction in panic disorder: a prospective case series. Arq Neuropsiquiatr. 2011;69(2A):196–201.21537560
  • Staab JP, Ruckenstein MJ, Solomon D, Shepard NT. Serotonin reuptake inhibitors for dizziness with psychiatric symptoms. Arch Otolaryngol Head Neck Surg. 2002;128(5):554–560.12003587
  • Jacob RG, Whitney SL, Detweiler-Shostak G, Furman JM. Vestibular rehabilitation for patients with agoraphobia and vestibular dysfunction: a pilot study. J Anxiety Disord. 2001;15(1–2):131–146.11388356
  • Cox BJ, Swinson RP. Instrument to assess depersonalization-derealization in panic disorder. Depress Anxiety. 2002;15(4):172–175. doi:10.1002/da.1005112112722